home our story events blog neuroblastoma media links shop contact us DONATE
chasing charlie’s cure

from stage 4 high-risk neuroblastoma

Details of the vaccine trial can be found here.

A journal article published in 2014 presenting outcomes of relapsed patients treated with the vaccine at Memorial Sloan Kettering Cancer Center (MSKCC):

Phase I Trial of a Bivalent Gangliosides Vaccine in Combination with β-Glucan for High-Risk Neuroblastoma in Second or Later Remission

Brian H. Kushner, Irene Y. Cheung, Shakeel Modak, Kim Kramer, Govind Ragupathi and Nai-Kong V. Cheung

2018 Update from MSKCC about their vaccine and other immunotherapy treatment (skip the first 25mins)

Band of Parents, helping to fund MSKCC’s vital work.

Vaccine Therapy…

Email

Sign-up for updates Find us on Social Media